Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

Clinical trial NCT02903082 · TERMINATED

Trial details

NCT number: NCT02903082
Sponsor: University Hospital, Limoges
Status: TERMINATED
Study type: OBSERVATIONAL

Severe Sepsis Inflammatory Response Syndrome, Systemic

Start date: 2015-04-01
Primary completion: 2018-01-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.